Effect [qlco]
Serum [bdsu]
Level [qlco]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
considered [idcn]
Atherosclerosis [dsyn]
Modulator [mnob]
Monocyte [cell]
activity [dora]
Hormone replacement therapy [topp]
Currently [tmco]
investigated [ftcn]
Means [cnce]
Prevention [topp]
Atherosclerosis [dsyn]
Aim [idcn]
To [qlco]
Assess [acty]
Range [qnco]
Circulating [ftcn]
Levels [qlco]
postmenopausal [tmco]
Women [popg]
Correlation [qlco]
atherosclerotic [ftcn]
Burden [idcn]
effects [qlco]
Discontinuation [hlca]
Hormone replacement therapy [topp]
Serum [bdsu]
Level [qlco]
Methods [inpr]
This [euka]
Clinical Trial [resa]
prospective [resa]
investigated [ftcn]
postmenopausal [tmco]
Women [popg]
Increased [qnco]
Risk [qlco]
Cardiovascular event [fndg]
randomized [resa]
To [qlco]
Receive [qlco]
Hormone replacement therapy [topp]
mg% [qnco]
Sequential [idcn]
Progestagen [horm, phsu, strd]
Intima media thickness [clna]
Carotid [bpoc]
Arteries, Femoral [bpoc]
Measured [qlco]
Ultrasound [diap]
Serum [bdsu]
Level [qlco]
Cellular Adhesion [celf]
molecules [sbst]
Measured [qlco]
ELISA [lbpr]
Result [ftcn]
baseline [bodm]
Levels [qlco]
Overall [inpr]
Mean [qnco]
Maximum [qnco]
Intima media thickness [clna]
Correlated [qlco]
R- [spco]
P NOS [aapp, imft]
Levels [qlco]
Serum [bdsu]
Decreased [qnco]
months [tmco]
Hormone replacement therapy [topp]
months [tmco]
P NOS [aapp, imft]
Cellular Adhesion [celf]
molecules [sbst]
Decreased [qnco]
months [tmco]
Women [popg]
To [qlco]
Continue [idcn]
Discontinue [fndg]
treatment [ftcn]
months [tmco]
Women [popg]
Discontinue [fndg]
Hormone replacement therapy [topp]
N NOS [aapp, imft]
Levels [qlco]
Rose [plnt]
P NOS [aapp, imft]
lowered [spco]
Women [popg]
Continuing [idcn]
Hormone replacement therapy [topp]
Conclusion [idcn]
observations [resa]
Effect [qlco]
Reducing [qlco]
Serum [bdsu]
Level [qlco]
Cell Adhesion Molecules [aapp, bacs]
[c] [qnco]
Science [ocdi]
Rights [qlco]
Reserve [acty]
